Suehiro, Y., Hasegawa, A., Iino, T., Fujioka, E., Watanabe, N., Tanosaki, R., Utsunomiya, A., Choi, I., Matsuoka, M., Shiratsuchi, M., Teshima, T., Akashi, K., Uike, N., Okamura, J., & Kannagi, M. (n.d.). 533 Extended treatment-free interval with excellent life more than two years after autologous dendritic cell vaccine therapy targeting HTLV-1 Tax for previously treated adult T-cell leukemia/lymphoma: The follow-up kinetics of cytotoxic T lymphocytes and HTLV-1 viral load. European journal of cancer, 51, S115–. http://access.bl.uk/ark:/81055/vdc_100030628048.0x00003d